Want to see AU:ARX full AI Analyst Report?

Aroa Biosurgery Ltd (ARX) Price & Analysis

63 Followers

ARX Stock Chart & Stats

AU$0.56

AU$0.02(3.57%)

At close: Jul 27 4:00 PM EDT

AU$0.56

AU$0.02(3.57%)

Day’s Range― - ―

52-Week RangeAU$0.48 - AU$0.80

Previous CloseN/A

Volume338.11K

Average Volume (3M)128.12K

Market Cap

AU$181.60M

Enterprise ValueAU$196.49

Total Cash (Recent Filing)AU$22.60M

Total Debt (Recent Filing)AU$5.31M

Price to Earnings (P/E)40.8

Beta0.61

Next Earnings

Nov 26, 2026

EPS Estimate

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.01

Shares Outstanding345,902,650

10 Day Avg. Volume102,187

30 Day Avg. Volume128,122

Financial Highlights & Ratios

PEG Ratio-0.23

Price to Book (P/B)2.48

Price to Sales (P/S)2.23

P/FCF Ratio24.50

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$0.94

Price Target Upside67.86% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)0.02

Revenue Forecast (FY)AU$120.56M

Bulls Say, Bears Say

Bulls Say

Strong Revenue GrowthThe substantial multi-year increase in revenue indicates expanding commercial adoption of Aroa’s ECM products and broader market penetration. Continued growth in hospital, surgical, and wound-care demand can provide operating leverage and create a stronger base for future earnings expansion.

High Gross MarginsConsistently high gross margins suggest Aroa’s specialized biomaterial products retain meaningful value after production costs. This provides room to support commercial investment, absorb operating expenses, and convert additional revenue growth into stronger profitability as scale improves.

Conservative Balance SheetLow leverage and substantial equity provide financial resilience as Aroa expands its product reach and commercial infrastructure. Limited debt reduces interest and refinancing pressure, while the equity cushion gives management greater flexibility to fund operations and pursue growth.

Bears Say

Profitability Recently Turned PositiveThe earnings turnaround is encouraging, but several consecutive years of losses mean the current profit level has not yet been demonstrated across a full operating cycle. Sustained execution will be needed to establish that positive earnings are durable rather than an early-stage inflection.

Volatile Cash GenerationThe recent improvement in cash generation is not yet supported by a long track record of consistency. Prior negative operating and free cash flow periods indicate that revenue growth has not always translated into liquidity, creating an ongoing need to prove reliable cash conversion.

Modest Net ProfitabilityDespite strong gross margins, only a modest portion of revenue currently reaches net income, showing that operating costs still absorb much of the value created. Low profitability and historically negative returns on equity could limit internally funded growth until margins broaden.

Aroa Biosurgery Ltd News

Aroa Biosurgery to Brief Investors on Interim MASTRR Registry Findings

Aroa Biosurgery Ltd ( ($AU:ARX) ) has shared an update. Aroa Biosurgery will host an investor webinar on...

4d ago

ARX

Aroa Biosurgery Study Shows Low Infection Rates for Myriad Bioscaffold

Aroa Biosurgery Ltd ( ($AU:ARX) ) has provided an announcement. Aroa Biosurgery has reported interim results from its...

29d ago

ARX

Aroa Biosurgery Issues New Unquoted Equity Under Employee Incentive Schemes

Aroa Biosurgery Ltd ( ($AU:ARX) ) has issued an update. Aroa Biosurgery Limited has issued new unquoted equity...

1M ago

ARX

Aroa Biosurgery Director John Diddams Steps Down but Retains Indirect Stake

Aroa Biosurgery Ltd ( ($AU:ARX) ) has provided an update. Aroa Biosurgery Limited has announced that director John...

1M ago

ARX

Aroa Biosurgery shareholders back all resolutions at Annual General Meeting

The latest update is out from Aroa Biosurgery Ltd ( ($AU:ARX) ). Aroa Biosurgery Limited reported the results...

1M ago

ARX

Aroa Biosurgery Issues Investor Education Presentation With Key Disclaimers

Aroa Biosurgery Ltd ( ($AU:ARX) ) has shared an announcement. Aroa Biosurgery has released an investor-focused presentation outlining...

1M ago

ARX

Aroa Biosurgery Issues New Restricted Stock Units Under Employee Scheme

Aroa Biosurgery Ltd ( ($AU:ARX) ) has shared an update. Aroa Biosurgery Ltd has notified the market of...

2M ago

ARX

Aroa Biosurgery Issues 2.9 Million Restricted Stock Units Under Employee Incentive Plan

Aroa Biosurgery Ltd ( ($AU:ARX) ) just unveiled an announcement. Aroa Biosurgery Limited has notified the market of...

2M ago

ARX

Aroa Biosurgery strengthens US commercial leadership to drive global growth

Aroa Biosurgery Ltd ( ($AU:ARX) ) has shared an update. Aroa Biosurgery has expanded its US-based commercial leadership...

2M ago

ARX

Aroa Biosurgery Sets Fully Virtual 2026 AGM with Governance and CEO Incentive Votes

Aroa Biosurgery Ltd ( ($AU:ARX) ) has provided an announcement. Aroa Biosurgery Limited has scheduled its 2026 Annual...

2M ago

ARX

ARX FAQ

What was Aroa Biosurgery Ltd’s price range in the past 12 months?

Aroa Biosurgery Ltd lowest share price was AU$0.48 and its highest was AU$0.80 in the past 12 months.

What is Aroa Biosurgery Ltd’s market cap?

Aroa Biosurgery Ltd’s market cap is AU$181.60M.

When is Aroa Biosurgery Ltd’s upcoming earnings report date?

Aroa Biosurgery Ltd’s upcoming earnings report date is Nov 26, 2026 which is in 55 days.

How were Aroa Biosurgery Ltd’s earnings last quarter?

Aroa Biosurgery Ltd released its earnings results on May 25, 2026. The company reported AU$0.016 earnings per share for the quarter, beating the consensus estimate of AU$0.004 by AU$0.012.

Is Aroa Biosurgery Ltd overvalued?

According to Wall Street analysts Aroa Biosurgery Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Aroa Biosurgery Ltd pay dividends?

Aroa Biosurgery Ltd does not currently pay dividends.

What is Aroa Biosurgery Ltd’s EPS estimate?

Aroa Biosurgery Ltd’s EPS estimate is 0.

How many shares outstanding does Aroa Biosurgery Ltd have?

Aroa Biosurgery Ltd has 345,902,650 shares outstanding.

What happened to Aroa Biosurgery Ltd’s price movement after its last earnings report?

Aroa Biosurgery Ltd reported an EPS of AU$0.016 in its last earnings report, beating expectations of AU$0.004. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aroa Biosurgery Ltd?

Currently, no hedge funds are holding shares in AU:ARX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Aroa Biosurgery Ltd Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

1.55%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Aroa Biosurgery Ltd

Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.

Aroa Biosurgery Ltd (ARX) Earnings & Revenues

Historic Earnings Reports

ARX Stock 12 Month Forecast

Average Price Target

AU$0.94

▲(67.86% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"AU$2","-1":"-AU$1","-0.25":"-AU$0.25","0.5":"AU$0.5","1.25":"AU$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.09,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$1.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.9400000000000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$0.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$0.79</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.49,0.5361538461538462,0.5823076923076923,0.6284615384615385,0.6746153846153846,0.7207692307692308,0.766923076923077,0.8130769230769231,0.8592307692307692,0.9053846153846155,0.9515384615384617,0.9976923076923078,1.0438461538461539,{"y":1.09,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.49,0.5246153846153846,0.5592307692307692,0.5938461538461538,0.6284615384615384,0.6630769230769231,0.6976923076923077,0.7323076923076923,0.7669230769230769,0.8015384615384615,0.8361538461538461,0.8707692307692307,0.9053846153846155,{"y":0.9400000000000001,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.49,0.5130769230769231,0.5361538461538462,0.5592307692307692,0.5823076923076923,0.6053846153846154,0.6284615384615385,0.6515384615384616,0.6746153846153846,0.6976923076923077,0.7207692307692308,0.7438461538461538,0.766923076923077,{"y":0.79,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.68,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.78,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.66,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.73,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.64,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.66,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.59,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.62,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.655,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.59,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.57,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.55,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.49,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >